ClinicalThought

Share

Program Content

Activities

  • Key Issues in Myeloma
    Key Issues in Myeloma Treatment Today
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 23, 2020

    Expires: November 22, 2021

  • FAQ in Myeloma
    Experts Answer Frequently Asked Questions on Myeloma Management
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 27, 2021

    Expires: January 26, 2022

Faculty

cover img faculity

Brian G. M. Durie, MD

National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.
Co-Chair, Myeloma Committee – SWOG
Chairman, International Myeloma Foundation
Specialist, Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Bristol Myers Squibb

GlaxoSmithKline

Karyopharm

Oncopeptides

Partners

International Myeloma Foundation

ProCE Banner